Bumper Offer - Urjas oil Just @ Rs. 1 X
Rifnim 400 Mg Tablet is a commercial drug that is prescribed in the form of Tablet. Hepatic Encephalopathy are some of its major therapeutic uses. Secondary and off-label uses of Rifnim 400 Mg Tablet have also been mentioned below.
The right dosage of Rifnim 400 Mg Tablet depends on the age, gender, and medical history of the patient. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. For detailed information on this, read through the dosage section.
The side effects typically associated with Rifnim 400 Mg Tablet include Flatulence, Bloating or fullness, Constipation. While these are the most often observed Rifnim 400 Mg Tablet side effects, there are can be others also. These have been listed below. Normally, these side effects of Rifnim 400 Mg Tablet are not long lasting and go away when the treatment is finished. If, however, they worsen or do not go away, please speak with your physician.
It is also important to note that Rifnim 400 Mg Tablet has a Severe effect for pregnant women and Severe effect on lactating mothers. In addition, Rifnim 400 Mg Tablet's effects on the liver, heart and kidney are discussed below in the Rifnim 400 Mg Tablet related warnings section.
The section on Rifnim 400 Mg Tablet contraindications lists all such conditions.
Drug reaction of Rifnim 400 Mg Tablet with other medicines has been reported. A complete list of these interactions is given below.
You should also be aware that Rifnim 400 Mg Tablet is safe while driving, and is addiction.
Rifnim 400 Mg Tablet is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| 13 - 18 years (Adolescent) |
|
| Geriatric |
|
Based on research, the following side effects have been observed when Rifnim 400 Mg Tablet is used -
Moderate
Mild
Common
Is the use of Rifnim 400 Mg Tablet safe for pregnant women?
Rifnim has many dangerous side effects in pregnant women. If you are pregnant, do not consume Rifnim without medical advice.
Is the use of Rifnim 400 Mg Tablet safe during breastfeeding?
Taking Rifnim may lead to serious side effects if you are breastfeeding. Rifnim should not be taken by breastfeeding women unless prescribed by the doctor.
What is the effect of Rifnim 400 Mg Tablet on the Kidneys?
Rifnim is not harmful for kidneys.
What is the effect of Rifnim 400 Mg Tablet on the Liver?
Side effects of Rifnim rarely affect the liver.
What is the effect of Rifnim 400 Mg Tablet on the Heart?
Rifnim is completely safe for the heart.
Rifnim 400 Mg Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Moderate
If you are suffering from any of the following diseases, you should not take Rifnim 400 Mg Tablet unless your doctor advises you to do so -
Is this Rifnim 400 Mg Tablet habit forming or addictive?
Rifnim 400 Mg Tablet is not addictive in nature.
Is it safe to drive or operate heavy machinery when consuming?
Yes, you can comfortably use machinery or drive after taking Rifnim 400 Mg Tablet since it will not make you feel sleepy.
Is it safe?
Yes, but consume Rifnim 400 Mg Tablet only on doctor's advice.
Is it able to treat mental disorders?
No, Rifnim 400 Mg Tablet cannot treat any kind of mental disorder.
Interaction between Food and Rifnim 400 Mg Tablet
It is safe to take Rifnim 400 Mg Tablet with food.
Interaction between Alcohol and Rifnim 400 Mg Tablet
No research has been done on this till date. Therefore, it is not known what the effect of taking Rifnim 400 Mg Tablet with alcohol will be.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Xifaxan® (rifaximin)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 681-683
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1096-1097
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Xifaxan® (rifaximin)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 681-683
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1096-1097
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Xifaxan® (rifaximin)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 681-683
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1096-1097